Biotechnology - Licensing, Management

Filter

Current filters:

LicensingManagement

Popular Filters

Big news day for Amicus, with change in GSK deal, an acquisition and restructuring

Big news day for Amicus, with change in GSK deal, an acquisition and restructuring

22-11-2013

US biotech firm Amicus Therapeutics saw its shares fall 4.2% to $2.03 by mid-morning trading on Thursday,…

Amicus TherapeuticsBiotechnologyCallidus BiopharmaFinancialGlaxoSmithKlineLicensingManagementMergers & AcquisitionsmigalastatRare diseases

Merck Serono sets up Prexton Therapeutics as first spin-off from its Entrepreneur Partnership Program

31-07-2012

Merck Serono, a division of Germany's Merck KGaA (MRK: DE), has created Prexton Therapeutics, the first…

BiotechnologyLicensingManagementMerck KGaAMerck SeronoNeurologicalPharmaceuticalPrexton TherapeuticsResearch

Back to top